Production of Ouabain-Like Factor in Normal and Ischemic Rat Heart

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 5, 2004, Pages 657-662

  D'Urso, Giuseppina ^a   Frascarelli, Sabina ^a   Balzan, Silvana ^b   Zucchi, Riccardo ^a   Montali, Umberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Digitalis; Inotropic agents; Ischemia; Na+ K+ pump; Ouabain like factor

Indexed keywords

DIGITALIS LIKE FACTOR; HEART MUSCLE EXTRACT; RUBIDIUM 86;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOTHALAMUS; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; CARDENOLIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGOXIN; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SAPONINS;

EID: 2042532647     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200405000-00007     Document Type: Article

References (35)

1. Ludens JH, Clark MA, DuCharme DW, et al. Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension. 1991;17:923-929.
2. Hamlyn JM, Blaustein MP, Bova S, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA. 1991;88:6259-6263.
3. Goto A, Yamada K. Ouabain-like factor. Curr Opin Nephrol 1998;7:189-196.
4. Dmitrieva RI, Bagrov AY, Lalli E, et al. Mammalian bufadienolide is synthesised from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension. 2000; 36:442-448.
5. Li S, Eim C, Kirch U, et al. Bovine adrenals and hypotalamus are a major source of proscillaridin A and ouabain-immunoreactivities. Life Sci. 1998;62:1023-1033.
6. +-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 1995;34:9893-9896.
7. Schneider R, Wray V, Nimtz M, et al. Bovine adrenal contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem. 1998; 273:784-792.
8. Kawamura A, Guo J, Itagaki Y, et al. On the structure of endogenous ouabain. Proc Natl Acad Sci USA. 1999;96:6654-6659.
9. Laredo J, Hamilton JP, Hamlyn JM. Secretion of endogenous ouabain from bovin adrenal cells. Role of zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun. 1995;212:487-493.
10. Goto A, Yamada K. An approach to the development of novel antihypertensive drugs: potential role of sodium pump inhibitors. Trends Pharmacol Sci. 1998;19:201-204.
11. Laredo J, Shah JR, Lu Z, et al. Angiotensin 11 stimulates secretion of endogenous ouabain from bovine adrenal cortical cells via angiotensin 11 receptors. Hypertension. 1997;29:401-407.
12. +-ATPase and Related ATPase. Amsterdam: Elsevier; 2000:671-679.
13. Komiyama Y, Nishimura N, Munakata M, et al. Identification of endogenous ouabain in culture supernatant of PC12 cells. J Hypertens. 2001; 19:229-236.
14. 2+ stores and cell responsiveness. Am J Physiol. 1993;264: C1367-C1387.
15. Hamlyn JM, Lu Z, Manunta P, et al. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin Exp Hypertens. 1998;20:523-533.
16. Gottlieb SS, Rogovski AC, Weinberg M, et al. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation. 1992;86:420-425.
17. +-ATPase with high sodium intake in patients with essential hypertension. J Clin Hypertens. 1987;3:419-429.
18. Balzan S, Neglia D, Ghione S, et al. Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur J Heart Fail. 2001;3:165-171.
19. Antolovic R, Bauer N, Mohadjerani M, et al. Endogenous ouabain and its binding globulin: effect of physical exercise and study on its tissue distribution. Hypertens Res. 2000;23(Suppl):S93-98.
20. Aizman O, Uhlén P, Lal M, et al. Ouabain, a steroid hormone that signals with slow calcium oscillation. Proc Natl Acad Sci USA. 2001;98:13420-13424.
21. 2+ concentrations. J Biol Chem. 2000;275:27838-27844.
22. Harris DW, Clark MA, Fisher JF, et al. Development of an immunoassay for endogenous digitalislike factor. Hypertension. 1991;17:93-143.
23. Ferrandi M, Manunta P, Balzan S, et al. Ouabain-like factor quantification in mammalian tissues and plasma. Comparison of two independent assays. Hypertension. 1997;30:886-896.
24. 2+ channels. Circ Res. 1994;74:271-280.
25. 2+ channel: A possible mechanism of ischemic preconditioning. Circ Res. 1995;76:1049-1056.
26. Di Bartolo V, Balzan S, Pieraccini L, et al. Evidence for an endogenous ouabain-like immunoreactive factor in human plasma coeluted with ouabain on HPLC. Life Sci. 1995;57:1417-1425.
27. 86Rb uptake by erythrocytes in extracts of human plasma. Clin Sci. 1989;77:375-381.
28. Rossi GP, Manunta P, Hamlyn JM, et al. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995;13:1181-1191.
29. 3H]ouabain from the cell surface into the lysosomal compartment of HeLa cells. J Cell Physiol. 1982; 110:84-92.
30. +-ATPase in living cells. Proc Natl Acad Sci USA. 1989;86:544-588.
31. Kolbeck-Ruhmkorff C, Horban A, Zimmer HG. Effect of pressure and volume overload on proto-oncogene expression in the isolated working rat heart. Cardiovasc Res. 1993;27:1998-2004.
32. Roffe C, MacDiarmaid-Gordon A, Ohanian V, et al. The effect of after-load and angiotcnsin 11 on proto-oncogene mRNA levels in the isolated working rat heart. Cardiovasc Res. 1996;31:907-116.
33. Plumier JC, Robertson HA, Currie RW. Differential accumulation of mRNA for immediate early genes and heat shock genes in heart after ischemia injury. J Mol Cell Cardiol. 1996;28:1251-1260.
34. Jones WK, Flaherty MP, Tang XL, et al. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism. J Mol Cell Cardiol. 1999;31:1469-1481.
35. Temsah RM, Kawabata K, Chapman D, Dhalla NJ. Modulation of cardiac sarcoplasmic reticulum gene expression by lack of oxygen and glucose. FASEB J. 2001;15:25157 (DOI 10.1096/fj.00-0870fje).